dpp4i and glp 1 agonist GLP-1 receptor versus DPP-4 inhibitor kidney and cardiovascular outcomes in clinical practice in type-2 diabetes Frontiers | Mechanisms of action

Plagman A, Hoscheidt S, McLimans KE et al (2019) Cholecystokinin and Alzheimers disease: a biomarker of metabolic function, neural integrity, and cognitive performance

Epithalon addresses this at the source, stimulating the gland rather than bypassing it

Lysosomal lipid peroxidation regulates tumor immunity

A systematic review of 17 clinical studies involving over 25,000 subjects showed that increased systemic TMAO concentrations were correlated with higher cardiovascular events, and the relative risk of all-cause mortality was shown to increase by 7.6% per 10 mol/L increments of plasma TMAO concentration (Schiattarella et al., 2017)

doi: 10.3390/foods8030092, 122